PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI)

8 filings reported holding PALI - PALISADE BIO, INC. - Common Stock, par value $0.01 per share as of Q3 2024.
PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 62.1K shares of 100M outstanding shares and own 0.06% of the company stock.
Largest 8 shareholders include ARMISTICE CAPITAL, LLC (52K shares), JPMORGAN CHASE & CO (8.2K shares), Tower Research Capital LLC (TRC) (1.6K shares), MORGAN STANLEY (140 shares), Federation des caisses Desjardins du Quebec (100 shares), UBS Group AG (31 shares), WELLS FARGO & COMPANY/MN (21 shares), and BANK OF AMERICA CORP /DE/ (9 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.